Centre for Infectious Disease Control, National Institute for Public Health and Environment, Bilthoven, The Netherlands.
Epidemiol Infect. 2011 Sep;139(9):1332-41. doi: 10.1017/S0950268810002621. Epub 2010 Nov 19.
Data about the effectiveness of different antibiotic regimens for the treatment of acute Q fever from clinical studies is scarce. We analysed the antibiotic treatment regimens of acute Q fever patients in 2007 and 2008 in The Netherlands and assessed whether hospitalization after a minimum of 2 days antibiotic therapy was related to the initial antibiotic therapy. Clinical data on antibiotic treatment and risk factors of acute Q fever patients were obtained from general practitioner medical records and self-reported by patients. For the 438 study patients, doxycycline was the most commonly prescribed initial antibiotic in both study years. After adjustments for confounding factors, doxycycline (200 mg/day), moxifloxacin, as well as other possibly effective antibiotics [including other new fluoroquinolones and doxycycline (100 mg/day)] showed significant lower risks for hospitalization compared to β-lactam antibiotics and azithromycin (reference group), with the lowest risk for doxycycline (200 mg/day) (odds ratio 0·04, 95% confidence interval 0·01-0·22). These data support current guidelines that recommend doxycycline as the first choice antibiotic for treating acute Q fever.
关于不同抗生素方案治疗急性 Q 热的有效性的临床研究数据很少。我们分析了 2007 年和 2008 年荷兰急性 Q 热患者的抗生素治疗方案,并评估了在至少 2 天抗生素治疗后住院是否与初始抗生素治疗有关。急性 Q 热患者的抗生素治疗临床数据和危险因素来自全科医生的病历,并由患者自行报告。在 438 名研究患者中,多西环素是这两年研究中最常开的初始抗生素。在调整混杂因素后,与β-内酰胺类抗生素和阿奇霉素(参照组)相比,多西环素(200mg/天)、莫西沙星以及其他可能有效的抗生素[包括其他新型氟喹诺酮类和多西环素(100mg/天)]显示出较低的住院风险,其中多西环素(200mg/天)的风险最低(比值比 0.04,95%置信区间 0.01-0.22)。这些数据支持当前的指南,即建议多西环素作为治疗急性 Q 热的首选抗生素。